Ads
related to: Skyrizi- SKYRIZI® Dosing Info
Learn About The Dosing Frequency Of
SKYRIZI®. See Results For SKYRIZI®.
- After SKYRIZI
See Results From SKYRIZI
For Real Clinical Trial Patients.
- Register For More Info
Be The First To Know About
SKYRIZI Info. Sign Up Now.
- SKYRIZI Resources
Skyrizi Complete Offers Resources
To Stay On Track With Treatment.
- SKYRIZI Results
See Results from SKYRIZI
From Real Clinical Trial Patients.
- Doctor Discussion Tool
Use Our Free Tool To Help
Prepare For Your Next Visit.
- SKYRIZI® Dosing Info
Search results
AbbVie's (ABBV) Skyrizi Gets EU Nod for Crohn's Disease
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced that the European Commission has granted approval to its drug Skyrizi...
Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication
Zacks via Yahoo Finance· 1 year agoThis week, Merck MRK offered to buy Imago Biosciences IMGO, which is developing drugs to treat bone...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
Reuters via Yahoo News· 3 months ago(Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and...
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
Motley Fool via Yahoo Finance· 3 months agoThere are thousands of drugs on the market, and there are thousands more that are no longer in use....
AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Investor's Business Daily· 2 weeks agoFears that Humira biosimilars will erode AbbVie's top line are overblown, an analyst said Monday as...
Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoAbbVie’s ABBV fourth-quarter revenues are likely to be driven by revenues generated from the sales...
AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 10 months agoAbbVie's (ABBV) Q2 performance will likely reflect Skyrizi and Rinvoq sales trying to make up for...
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q4 2023 Earnings Call Feb 02, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $3.60 per share for the fourth quarter of 2022,...
Ad
related to: Skyrizi
